Dendritic Cell Vaccine: all 22 studies that test it

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without AntiretroviralsRecruitingNCT06805656Phase 2
• Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for GlioblastomaNot yet recruitingNCT06749925Phase 3
• Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant TherapyRecruitingNCT06435351Early Phase 1
• NEOadjuvant Dendritic Cell Vaccination for Ovarian CancerRecruitingNCT05773859Phase 1/2
• T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With MelanomaRecruitingNCT01946373Phase 1
• A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)Active, not recruitingNCT05809752Phase 1
• Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast CancerSuspendedNCT05378464Phase 1
• IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal MelanomaCompletedNCT04335890Phase 1
• HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast CancerCompletedNCT03387553Early Phase 1
• Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast CancerStatus unknownNCT03113019Early Phase 1
• Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing CureCompletedNCT02961829Not applicable
• A Combined Cell Therapy Approach to the Treatment of NeuroblastomaWithdrawnNCT02745756Phase 1
• Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain TumorsTerminatedNCT01902771Phase 1
• Dendritic Cell (DC) Vaccine for Malignant Glioma and GlioblastomaCompletedNCT01808820Phase 1
• Randomized Trial With Dendritic Cells in Patients With Metastatic Colorectal CancerCompletedNCT01413295Phase 2
• Vaccine Therapy in Curative Resected Prostate Cancer PatientsActive, not recruitingNCT01197625Phase 1/2
• Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)CompletedNCT00796770Phase 1
• Immune Responses To Antigen-Bearing Dendritic Cells in Patients With MalignancyCompletedNCT00700167Phase 1
• Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma PatientsCompletedNCT00576446Phase 1
• Dendritic Cell Vaccine for Head and Neck CancerWithdrawnNCT00492947Phase 1
• Dendritic Cell Vaccine in HIV-1 InfectionCompletedNCT00402142Phase 1/2
• Dendritic Cell Based Therapy of Malignant MelanomaCompletedNCT00197912Phase 1/2

← Dendritic Cell Vaccine overview